Pharmaceutical

Remote Patient Monitoring market will reach $760m by 2030

A new report found that the Remote Patient Monitoring (RPM) sector will grow, since the pandemic revealed the benefits of remote healthcare.

Sep 15, 2023 - 20:00
Remote Patient Monitoring market will reach $760m by 2030
A new report found that the Remote Patient Monitoring (RPM) sector will grow, since the pandemic revealed the benefits of remote healthcare.
Read the original article

Tags:

Previous Article

NICE recommends Idorsia’s chronic insomnia treatment for UK patients

Next Article

Iovance’s PDUFA date for lifileucel pushed due to FDA backlog

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Key Senate panel to consider PBM, drug pricing reform package

STAT+: Key Senate panel to consider PBM, drug pricing r...

Nov 3, 2023

China’s NMPA approves Antengene’s XPOVIO for DLBCL

China’s NMPA approves Antengene’s XPOVIO for DLBCL

Jul 10, 2024

Opinion: STAT+: It’s time to rethink everything about our approach to psychiatric drug development

Opinion: STAT+: It’s time to rethink everything about o...

Mar 8, 2024